Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines†. Ann Oncol 7(suppl_5):v111–8
2. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018) [Internet]. [cited 2019 Jun 15]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339667/
3. Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C, et al. (2013) Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica 98(12):1836–47
4. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 52(4):427–431
5. Masaoka T (2004) Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis Off Publ Infect Dis Soc Am 15(39 Suppl 1):S49-52